Novabridge Biosciences ADR (NBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,654 | N/A | -49,696 | N/A | -18,360 |
| Depreciation Amortization | 424 | N/A | 978 | N/A | 569 |
| Other Working Capital | -198 | N/A | -2,811 | N/A | -19,669 |
| Other Operating Activity | 588 | 0 | -1,140 | 0 | -12,682 |
| Operating Cash Flow | $-7,840 | $N/A | $-52,669 | $N/A | $-50,142 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 104,925 | N/A | -84,914 | N/A | -35,304 |
| PPE Investments | 47 | N/A | 62 | N/A | 62 |
| Purchase Of Investment | N/A | N/A | -51,115 | N/A | -19,000 |
| Purchase Sale Intangibles | -7 | N/A | -48 | N/A | -9 |
| Other Investing Activity | -7 | 0 | -48 | 0 | -9 |
| Investing Cash Flow | $104,965 | $N/A | $-136,015 | $N/A | $-54,251 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | N/A | N/A | -335 | N/A | -335 |
| Financing Cash Flow | $N/A | $N/A | $-335 | $N/A | $-335 |
| Exchange Rate Effect | 16 | N/A | 573 | N/A | -20 |
| Beginning Cash Position | 68,263 | N/A | 310,667 | N/A | 310,667 |
| End Cash Position | 165,404 | N/A | 68,263 | N/A | 151,961 |
| Net Cash Flow | $97,141 | $N/A | $-242,404 | $N/A | $-158,706 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,840 | N/A | -52,669 | N/A | -50,142 |
| Free Cash Flow | -7,840 | 0 | -52,669 | 0 | -50,142 |